Screener
Marker Therapeutics, Inc. MRKR Q1 2025 Annual earnings
Reported May 21, 2025 · Before market open
Revenue$349.1KBeat by $174.6K
EPS-$0.27Beat by $0.39
Revenue estimate$174.6K
EPS estimate-$0.66
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$2.1M
EPS estimate-$0.12
Versus estimates
Revenue
Q4 2025$1.1MBeat by $417.9KQ3 2025$1.2MBeat by $509.9KQ2 2025$861.2KBeat by $430.6K
Q1 2025$349.1KBeat by $174.6K
Diluted EPS
FAQ
- When did Marker Therapeutics, Inc. report Q1 2025 earnings?
- Marker Therapeutics, Inc. (MRKR) reported Q1 2025 earnings on May 21, 2025 before market open.
- What were Marker Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Marker Therapeutics, Inc. reported revenue of $349.1K and eps of $-0.27 for Q1 2025.
- Did Marker Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $174.6K by $174.6K. EPS beat the consensus estimate of $-0.66 by $0.39.
- How did Marker Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 71.9% from $1.2M a year earlier and eps grew 0.0% from $-0.27.
- Where can I find Marker Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-050771) and the 10-K periodic report (0001410578-25-000549) directly on SEC EDGAR. The filing index links above go to sec.gov.
